Redwood Pharma AB: Quarterly Report January – September 2019
REDWOOD PHARMA AB (PUBL)Spotlight Stock Market: REDW redwoodpharma.com1 January – 30 September 2019 · The company’s net revenue for the period was TSEK 0 (0). · Operating loss for the period was TSEK -11,679 (-10,949). · Loss per share for the period was SEK -0.94 (-1.05). Third quarter, 1 July – 30 September 2019 · The company’s net revenue for the period was TSEK 0 (0). · Operating loss for the period was TSEK -4,053 (-3,785). · Loss per share for the period was SEK -0.34 (-0.31). Important Events During the Period · The final patient was recruited